Profil
Tanja Weber formerly worked at Agios Pharmaceuticals, Inc., as Vice President-Business Development, Sanofi Ventures, as Vice President-Business Development, and Epizyme, Inc., as SVP-Business Development & Alliance Management from 2019 to 2022.
Ms. Weber received her graduate degree from Ruprecht-Karls-Universität Heidelberg.
Anciens postes connus de Tanja Weber
| Sociétés | Poste | Fin |
|---|---|---|
| EPIZYME, INC. | Corporate Officer/Principal | 01/03/2022 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - |
Formation de Tanja Weber
| Ruprecht-Karls-Universität Heidelberg | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
